Global Gene Therapy Market Size, Status and Forecast 2022

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.

In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.

Market Analysis and Insights: Global Gene Therapy Market

The global Gene Therapy market size is projected to reach US$ 30490 million by 2027, from US$ 5354.5 million in 2020, at a CAGR of 27.6% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy market.

Global Gene Therapy Scope and Market Size

Gene Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Viral Gene Therapy

Non-Viral Gene Therapy

Neurological Diseases

Cancer

Other

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Biogen

Novartis

Gilead Sciences

Sarepta Therapeutics

Alnylam Pharmaceuticals

Amgen

Spark Therapeutics

Akcea Therapeutics

bluebird bio

Sunway Biotech

SIBIONO

AnGes

Orchard Therapeutics

Human Stem Cells Institute

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Viral Gene Therapy

1.2.3 Non-Viral Gene Therapy

1.3 Market by Application

1.3.1 Global Gene Therapy Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Neurological Diseases

1.3.3 Cancer

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

2.1 Global Gene Therapy Market Perspective (2016-2027)

2.2 Gene Therapy Growth Trends by Regions

2.2.1 Gene Therapy Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Gene Therapy Historic Market Share by Regions (2016-2021)

2.2.3 Gene Therapy Forecasted Market Size by Regions (2022-2027)

2.3 Gene Therapy Industry Dynamic

2.3.1 Gene Therapy Market Trends

2.3.2 Gene Therapy Market Drivers

2.3.3 Gene Therapy Market Challenges

2.3.4 Gene Therapy Market Restraints

3.1 Global Top Gene Therapy Players by Revenue

3.1.1 Global Top Gene Therapy Players by Revenue (2016-2021)

3.1.2 Global Gene Therapy Revenue Market Share by Players (2016-2021)

3.2 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Gene Therapy Revenue

3.4 Global Gene Therapy Market Concentration Ratio

3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2020

3.5 Gene Therapy Key Players Head office and Area Served

3.6 Key Players Gene Therapy Product Solution and Service

3.7 Date of Enter into Gene Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Gene Therapy Historic Market Size by Type (2016-2021)

4.2 Global Gene Therapy Forecasted Market Size by Type (2022-2027)

5.1 Global Gene Therapy Historic Market Size by Application (2016-2021)

5.2 Global Gene Therapy Forecasted Market Size by Application (2022-2027)

6.1 North America Gene Therapy Market Size (2016-2027)

6.2 North America Gene Therapy Market Size by Type

6.2.1 North America Gene Therapy Market Size by Type (2016-2021)

6.2.2 North America Gene Therapy Market Size by Type (2022-2027)

6.2.3 North America Gene Therapy Market Size by Type (2016-2027)

6.3 North America Gene Therapy Market Size by Application

6.3.1 North America Gene Therapy Market Size by Application (2016-2021)

6.3.2 North America Gene Therapy Market Size by Application (2022-2027)

6.3.3 North America Gene Therapy Market Size by Application (2016-2027)

6.4 North America Gene Therapy Market Size by Country

6.4.1 North America Gene Therapy Market Size by Country (2016-2021)

6.4.2 North America Gene Therapy Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7.1 Europe Gene Therapy Market Size (2016-2027)

7.2 Europe Gene Therapy Market Size by Type

7.2.1 Europe Gene Therapy Market Size by Type (2016-2021)

7.2.2 Europe Gene Therapy Market Size by Type (2022-2027)

7.2.3 Europe Gene Therapy Market Size by Type (2016-2027)

7.3 Europe Gene Therapy Market Size by Application

7.3.1 Europe Gene Therapy Market Size by Application (2016-2021)

7.3.2 Europe Gene Therapy Market Size by Application (2022-2027)

7.3.3 Europe Gene Therapy Market Size by Application (2016-2027)

7.4 Europe Gene Therapy Market Size by Country

7.4.1 Europe Gene Therapy Market Size by Country (2016-2021)

7.4.2 Europe Gene Therapy Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8.1 Asia-Pacific Gene Therapy Market Size (2016-2027)

8.2 Asia-Pacific Gene Therapy Market Size by Type

8.2.1 Asia-Pacific Gene Therapy Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Gene Therapy Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Gene Therapy Market Size by Type (2016-2027)

8.3 Asia-Pacific Gene Therapy Market Size by Application

8.3.1 Asia-Pacific Gene Therapy Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Gene Therapy Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Gene Therapy Market Size by Application (2016-2027)

8.4 Asia-Pacific Gene Therapy Market Size by Region

8.4.1 Asia-Pacific Gene Therapy Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Gene Therapy Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Gene Therapy Market Size (2016-2027)

9.2 Latin America Gene Therapy Market Size by Type

9.2.1 Latin America Gene Therapy Market Size by Type (2016-2021)

9.2.2 Latin America Gene Therapy Market Size by Type (2022-2027)

9.2.3 Latin America Gene Therapy Market Size by Type (2016-2027)

9.3 Latin America Gene Therapy Market Size by Application

9.3.1 Latin America Gene Therapy Market Size by Application (2016-2021)

9.3.2 Latin America Gene Therapy Market Size by Application (2022-2027)

9.3.3 Latin America Gene Therapy Market Size by Application (2016-2027)

9.4 Latin America Gene Therapy Market Size by Country

9.4.1 Latin America Gene Therapy Market Size by Country (2016-2021)

9.4.2 Latin America Gene Therapy Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Gene Therapy Market Size (2016-2027)

10.2 Middle East & Africa Gene Therapy Market Size by Type

10.2.1 Middle East & Africa Gene Therapy Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Gene Therapy Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Gene Therapy Market Size by Type (2016-2027)

10.3 Middle East & Africa Gene Therapy Market Size by Application

10.3.1 Middle East & Africa Gene Therapy Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Gene Therapy Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Gene Therapy Market Size by Application (2016-2027)

10.4 Middle East & Africa Gene Therapy Market Size by Country

10.4.1 Middle East & Africa Gene Therapy Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Gene Therapy Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Biogen

11.1.1 Biogen Company Details

11.1.2 Biogen Business Overview

11.1.3 Biogen Gene Therapy Introduction

11.1.4 Biogen Revenue in Gene Therapy Business (2016-2021)

11.1.5 Biogen Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Gene Therapy Introduction

11.2.4 Novartis Revenue in Gene Therapy Business (2016-2021)

11.2.5 Novartis Recent Development

11.3 Gilead Sciences

11.3.1 Gilead Sciences Company Details

11.3.2 Gilead Sciences Business Overview

11.3.3 Gilead Sciences Gene Therapy Introduction

11.3.4 Gilead Sciences Revenue in Gene Therapy Business (2016-2021)

11.3.5 Gilead Sciences Recent Development

11.4 Sarepta Therapeutics

11.4.1 Sarepta Therapeutics Company Details

11.4.2 Sarepta Therapeutics Business Overview

11.4.3 Sarepta Therapeutics Gene Therapy Introduction

11.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2016-2021)

11.4.5 Sarepta Therapeutics Recent Development

11.5 Alnylam Pharmaceuticals

11.5.1 Alnylam Pharmaceuticals Company Details

11.5.2 Alnylam Pharmaceuticals Business Overview

11.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction

11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2016-2021)

11.5.5 Alnylam Pharmaceuticals Recent Development

11.6 Amgen

11.6.1 Amgen Company Details

11.6.2 Amgen Business Overview

11.6.3 Amgen Gene Therapy Introduction

11.6.4 Amgen Revenue in Gene Therapy Business (2016-2021)

11.6.5 Amgen Recent Development

11.7 Spark Therapeutics

11.7.1 Spark Therapeutics Company Details

11.7.2 Spark Therapeutics Business Overview

11.7.3 Spark Therapeutics Gene Therapy Introduction

11.7.4 Spark Therapeutics Revenue in Gene Therapy Business (2016-2021)

11.7.5 Spark Therapeutics Recent Development

11.8 Akcea Therapeutics

11.8.1 Akcea Therapeutics Company Details

11.8.2 Akcea Therapeutics Business Overview

11.8.3 Akcea Therapeutics Gene Therapy Introduction

11.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2016-2021)

11.8.5 Akcea Therapeutics Recent Development

11.9 bluebird bio

11.9.1 bluebird bio Company Details

11.9.2 bluebird bio Business Overview

11.9.3 bluebird bio Gene Therapy Introduction

11.9.4 bluebird bio Revenue in Gene Therapy Business (2016-2021)

11.9.5 bluebird bio Recent Development

11.10 Sunway Biotech

11.10.1 Sunway Biotech Company Details

11.10.2 Sunway Biotech Business Overview

11.10.3 Sunway Biotech Gene Therapy Introduction

11.10.4 Sunway Biotech Revenue in Gene Therapy Business (2016-2021)

11.10.5 Sunway Biotech Recent Development

11.11 SIBIONO

11.11.1 SIBIONO Company Details

11.11.2 SIBIONO Business Overview

11.11.3 SIBIONO Gene Therapy Introduction

11.11.4 SIBIONO Revenue in Gene Therapy Business (2016-2021)

11.11.5 SIBIONO Recent Development

11.12 AnGes

11.12.1 AnGes Company Details

11.12.2 AnGes Business Overview

11.12.3 AnGes Gene Therapy Introduction

11.12.4 AnGes Revenue in Gene Therapy Business (2016-2021)

11.12.5 AnGes Recent Development

11.13 Orchard Therapeutics

11.13.1 Orchard Therapeutics Company Details

11.13.2 Orchard Therapeutics Business Overview

11.13.3 Orchard Therapeutics Gene Therapy Introduction

11.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2016-2021)

11.13.5 Orchard Therapeutics Recent Development

11.14 Human Stem Cells Institute

11.14.1 Human Stem Cells Institute Company Details

11.14.2 Human Stem Cells Institute Business Overview

11.14.3 Human Stem Cells Institute Gene Therapy Introduction

11.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2016-2021)

11.14.5 Human Stem Cells Institute Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Gene Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

    Table 2. Key Players of Viral Gene Therapy

    Table 3. Key Players of Non-Viral Gene Therapy

    Table 4. Global Gene Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

    Table 5. Global Gene Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

    Table 6. Global Gene Therapy Market Size by Regions (2016-2021) & (US$ Million)

    Table 7. Global Gene Therapy Market Share by Regions (2016-2021)

    Table 8. Global Gene Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)

    Table 9. Global Gene Therapy Market Share by Regions (2022-2027)

    Table 10. Gene Therapy Market Trends

    Table 11. Gene Therapy Market Drivers

    Table 12. Gene Therapy Market Challenges

    Table 13. Gene Therapy Market Restraints

    Table 14. Global Gene Therapy Revenue by Players (2016-2021) & (US$ Million)

    Table 15. Global Gene Therapy Market Share by Players (2016-2021)

    Table 16. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy as of 2020)

    Table 17. Ranking of Global Top Gene Therapy Companies by Revenue (US$ Million) in 2020

    Table 18. Global 5 Largest Players Market Share by Gene Therapy Revenue (CR5 and HHI) & (2016-2021)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Gene Therapy Product Solution and Service

    Table 21. Date of Enter into Gene Therapy Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Gene Therapy Market Size by Type (2016-2021) (US$ Million)

    Table 24. Global Gene Therapy Revenue Market Share by Type (2016-2021)

    Table 25. Global Gene Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)

    Table 26. Global Gene Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)

    Table 27. Global Gene Therapy Market Size Share by Application (2016-2021) & (US$ Million)

    Table 28. Global Gene Therapy Revenue Market Share by Application (2016-2021)

    Table 29. Global Gene Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)

    Table 30. Global Gene Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)

    Table 31. North America Gene Therapy Market Size by Type (2016-2021) (US$ Million)

    Table 32. North America Gene Therapy Market Size by Type (2022-2027) & (US$ Million)

    Table 33. North America Gene Therapy Market Size by Application (2016-2021) (US$ Million)

    Table 34. North America Gene Therapy Market Size by Application (2022-2027) & (US$ Million)

    Table 35. North America Gene Therapy Market Size by Country (2016-2021) & (US$ Million)

    Table 36. North America Gene Therapy Market Size by Country (2022-2027) & (US$ Million)

    Table 37. Europe Gene Therapy Market Size by Type (2016-2021) (US$ Million)

    Table 38. Europe Gene Therapy Market Size by Type (2022-2027) & (US$ Million)

    Table 39. Europe Gene Therapy Market Size by Application (2016-2021) (US$ Million)

    Table 40. Europe Gene Therapy Market Size by Application (2022-2027) & (US$ Million)

    Table 41. Europe Gene Therapy Market Size by Country (2016-2021) & (US$ Million)

    Table 42. Europe Gene Therapy Market Size by Country (2022-2027) & (US$ Million)

    Table 43. Asia-Pacific Gene Therapy Market Size by Type (2016-2021) (US$ Million)

    Table 44. Asia-Pacific Gene Therapy Market Size by Type (2022-2027) & (US$ Million)

    Table 45. Asia-Pacific Gene Therapy Market Size by Application (2016-2021) (US$ Million)

    Table 46. Asia-Pacific Gene Therapy Market Size by Application (2022-2027) & (US$ Million)

    Table 47. Asia-Pacific Gene Therapy Market Size by Region (2016-2021) & (US$ Million)

    Table 48. Asia-Pacific Gene Therapy Market Size by Region (2022-2027) & (US$ Million)

    Table 49. Latin America Gene Therapy Market Size by Type (2016-2021) (US$ Million)

    Table 50. Latin America Gene Therapy Market Size by Type (2022-2027) & (US$ Million)

    Table 51. Latin America Gene Therapy Market Size by Application (2016-2021) (US$ Million)

    Table 52. Latin America Gene Therapy Market Size by Application (2022-2027) & (US$ Million)

    Table 53. Latin America Gene Therapy Market Size by Country (2016-2021) & (US$ Million)

    Table 54. Latin America Gene Therapy Market Size by Country (2022-2027) & (US$ Million)

    Table 55. Middle East & Africa Gene Therapy Market Size by Type (2016-2021) (US$ Million)

    Table 56. Middle East & Africa Gene Therapy Market Size by Type (2022-2027) & (US$ Million)

    Table 57. Middle East & Africa Gene Therapy Market Size by Application (2016-2021) (US$ Million)

    Table 58. Middle East & Africa Gene Therapy Market Size by Application (2022-2027) & (US$ Million)

    Table 59. Middle East & Africa Gene Therapy Market Size by Country (2016-2021) & (US$ Million)

    Table 60. Middle East & Africa Gene Therapy Market Size by Country (2022-2027) & (US$ Million)

    Table 61. Biogen Company Details

    Table 62. Biogen Business Overview

    Table 63. Biogen Gene Therapy Product

    Table 64. Biogen Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 65. Biogen Recent Development

    Table 66. Novartis Company Details

    Table 67. Novartis Business Overview

    Table 68. Novartis Gene Therapy Product

    Table 69. Novartis Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 70. Novartis Recent Development

    Table 71. Gilead Sciences Company Details

    Table 72. Gilead Sciences Business Overview

    Table 73. Gilead Sciences Gene Therapy Product

    Table 74. Gilead Sciences Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 75. Gilead Sciences Recent Development

    Table 76. Sarepta Therapeutics Company Details

    Table 77. Sarepta Therapeutics Business Overview

    Table 78. Sarepta Therapeutics Gene Therapy Product

    Table 79. Sarepta Therapeutics Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 80. Sarepta Therapeutics Recent Development

    Table 81. Alnylam Pharmaceuticals Company Details

    Table 82. Alnylam Pharmaceuticals Business Overview

    Table 83. Alnylam Pharmaceuticals Gene Therapy Product

    Table 84. Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 85. Alnylam Pharmaceuticals Recent Development

    Table 86. Amgen Company Details

    Table 87. Amgen Business Overview

    Table 88. Amgen Gene Therapy Product

    Table 89. Amgen Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 90. Amgen Recent Development

    Table 91. Spark Therapeutics Company Details

    Table 92. Spark Therapeutics Business Overview

    Table 93. Spark Therapeutics Gene Therapy Product

    Table 94. Spark Therapeutics Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 95. Spark Therapeutics Recent Development

    Table 96. Akcea Therapeutics Company Details

    Table 97. Akcea Therapeutics Business Overview

    Table 98. Akcea Therapeutics Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 99. Akcea Therapeutics Recent Development

    Table 100. bluebird bio Company Details

    Table 101. bluebird bio Business Overview

    Table 102. bluebird bio Gene Therapy Product

    Table 103. bluebird bio Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 104. bluebird bio Recent Development

    Table 105. Sunway Biotech Company Details

    Table 106. Sunway Biotech Business Overview

    Table 107. Sunway Biotech Gene Therapy Product

    Table 108. Sunway Biotech Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 109. Sunway Biotech Recent Development

    Table 110. SIBIONO Company Details

    Table 111. SIBIONO Business Overview

    Table 112. SIBIONO Gene Therapy Product

    Table 113. SIBIONO Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 114. SIBIONO Recent Development

    Table 115. AnGes Company Details

    Table 116. AnGes Business Overview

    Table 117. AnGes Gene Therapy Product

    Table 118. AnGes Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 119. AnGes Recent Development

    Table 120. Orchard Therapeutics Company Details

    Table 121. Orchard Therapeutics Business Overview

    Table 122. Orchard Therapeutics Gene Therapy Product

    Table 123. Orchard Therapeutics Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 124. Orchard Therapeutics Recent Development

    Table 125. Human Stem Cells Institute Company Details

    Table 126. Human Stem Cells Institute Business Overview

    Table 127. Human Stem Cells Institute Gene Therapy Product

    Table 128. Human Stem Cells Institute Revenue in Gene Therapy Business (2016-2021) & (US$ Million)

    Table 129. Human Stem Cells Institute Recent Development

    Table 130. Research Programs/Design for This Report

    Table 131. Key Data Information from Secondary Sources

    Table 132. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Gene Therapy Market Share by Type: 2020 VS 2027

    Figure 2. Viral Gene Therapy Features

    Figure 3. Non-Viral Gene Therapy Features

    Figure 4. Global Gene Therapy Market Share by Application: 2020 VS 2027

    Figure 5. Neurological Diseases Case Studies

    Figure 6. Cancer Case Studies

    Figure 7. Other Case Studies

    Figure 8. Gene Therapy Report Years Considered

    Figure 9. Global Gene Therapy Market Size (US$ Million), Year-over-Year: 2016-2027

    Figure 10. Global Gene Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027

    Figure 11. Global Gene Therapy Market Share by Regions: 2020 VS 2027

    Figure 12. Global Gene Therapy Market Share by Regions (2022-2027)

    Figure 13. Global Gene Therapy Market Share by Players in 2020

    Figure 14. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy as of 2020

    Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy Revenue in 2020

    Figure 16. Global Gene Therapy Revenue Market Share by Type (2016-2021)

    Figure 17. Global Gene Therapy Revenue Market Share by Type (2022-2027)

    Figure 18. North America Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 19. North America Gene Therapy Market Share by Type (2016-2027)

    Figure 20. North America Gene Therapy Market Share by Application (2016-2027)

    Figure 21. North America Gene Therapy Market Share by Country (2016-2027)

    Figure 22. United States Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 23. Canada Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 24. Europe Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 25. Europe Gene Therapy Market Share by Type (2016-2027)

    Figure 26. Europe Gene Therapy Market Share by Application (2016-2027)

    Figure 27. Europe Gene Therapy Market Share by Country (2016-2027)

    Figure 28. Germany Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 29. France Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 30. U.K. Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 31. Italy Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 32. Russia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 33. Nordic Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 34. Asia-Pacific Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 35. Asia-Pacific Gene Therapy Market Share by Type (2016-2027)

    Figure 36. Asia-Pacific Gene Therapy Market Share by Application (2016-2027)

    Figure 37. Asia-Pacific Gene Therapy Market Share by Region (2016-2027)

    Figure 38. China Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 39. Japan Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 40. South Korea Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 41. Southeast Asia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 42. India Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 43. Australia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 44. Latin America Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 45. Latin America Gene Therapy Market Share by Type (2016-2027)

    Figure 46. Latin America Gene Therapy Market Share by Application (2016-2027)

    Figure 47. Latin America Gene Therapy Market Share by Country (2016-2027)

    Figure 48. Mexico Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 49. Brazil Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 50. Middle East & Africa Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 51. Middle East & Africa Gene Therapy Market Share by Type (2016-2027)

    Figure 52. Middle East & Africa Gene Therapy Market Share by Application (2016-2027)

    Figure 53. Middle East & Africa Gene Therapy Market Share by Country (2016-2027)

    Figure 54. Turkey Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 55. Saudi Arabia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 56. UAE Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)

    Figure 57. Biogen Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 58. Novartis Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 59. Gilead Sciences Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 60. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 61. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 62. Amgen Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 63. Spark Therapeutics Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 64. Akcea Therapeutics Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 65. bluebird bio Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 66. Sunway Biotech Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 67. SIBIONO Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 68. AnGes Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 69. Orchard Therapeutics Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 70. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy Business (2016-2021)

    Figure 71. Bottom-up and Top-down Approaches for This Report

    Figure 72. Data Triangulation

    Figure 73. Key Executives Interviewed